H19 and myeloid sarcoma: Several lncRNAs (THRIL, HOTAIR, TUG1, H19) show upregulation in active or progressive MS states, particularly in SPMS or relapse phases, linking them to inflammatory and immune signaling pathways (e.g., STAT3, NF-κB, TNF-α).